Variant report
Variant | esv3343678 |
---|---|
Chromosome Location | chr12:60452835-60454933 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140797440 | chr12:60453830-60453831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533314467 | chr12:60453831-60453832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547166482 | chr12:60453881-60453882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566866616 | chr12:60453898-60453899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12369823 | chr12:60453909-60453910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368110174 | chr12:60453913-60453914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535733391 | chr12:60453918-60453919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139812040 | chr12:60453959-60453960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547812562 | chr12:60453982-60453983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567692833 | chr12:60453986-60453987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537166582 | chr12:60453994-60453995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556741075 | chr12:60454026-60454027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531848325 | chr12:60454052-60454053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576972895 | chr12:60454062-60454063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539301892 | chr12:60454095-60454096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143026553 | chr12:60454145-60454146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573201804 | chr12:60454149-60454150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545047184 | chr12:60454157-60454158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11173308 | chr12:60454177-60454178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562079248 | chr12:60454190-60454191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575506558 | chr12:60454218-60454219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544693159 | chr12:60454234-60454235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564467984 | chr12:60454236-60454237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144677002 | chr12:60454240-60454241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546914603 | chr12:60454243-60454244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560293605 | chr12:60454275-60454276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187260333 | chr12:60454281-60454282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374777769 | chr12:60454286-60454287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs17123263 | chr12:60454295-60454296 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs148701283 | chr12:60454324-60454325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530379231 | chr12:60454377-60454378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111393145 | chr12:60454398-60454399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530188819 | chr12:60454405-60454406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570495996 | chr12:60454441-60454442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539496628 | chr12:60454466-60454467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553224561 | chr12:60454479-60454480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573307056 | chr12:60454489-60454490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566636851 | chr12:60454539-60454540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74681675 | chr12:60454572-60454573 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375533747 | chr12:60454595-60454596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs555651165 | chr12:60454628-60454629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs369478138 | chr12:60454659-60454660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374529381 | chr12:60454660-60454661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544318888 | chr12:60454682-60454683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558118861 | chr12:60454684-60454685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11173309 | chr12:60454801-60454802 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs78003781 | chr12:60454807-60454808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560332288 | chr12:60454877-60454878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs968106 | chr12:60454892-60454893 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs542917447 | chr12:60454907-60454908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:60453800-60454600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr12:60454000-60454600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr12:60454000-60454600 | Enhancers | NHEK | skin |
4 | chr12:60454200-60454400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr12:60454400-60464000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |